Leping Li

机构：Qingdao University, Shandong Provincial Hospital, Affiliated Hospital of Qingdao University, Shandong First Medical University, First Hospital of Lanzhou University, Lanzhou University · ORCID：0000-0003-2329-6791

发表论文 224 篇 · 总被引 4535 次 · h-index 36

代表论文

• Pembrolizumab Plus Chemotherapy Versus Chemotherapy as Perioperative Therapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer: Final Analysis of the Randomized, Phase III KEYNOTE-585 Study (2025 · Journal of Clinical Oncology · 被引 39)
• Neoadjuvant treatment of IBI310 plus sintilimab in locally advanced MSI-H/dMMR colon cancer: A randomized phase 1b study (2025 · Cancer Cell · 被引 23)
• The central signaling pathways related to metabolism-regulating hormones of the gut-brain axis: a review (2025 · Journal of Translational Medicine · 被引 18)
• Mechanism and Therapeutic Progress of One-Carbon Metabolic Key Enzyme: Serine Hydroxymethyltransferase 2 in Cancer (2025 · Clinical Medicine Insights Oncology · 被引 6)
• MALMPS: A Machine Learning‐Based Metabolic Gene Prognostic Signature for Stratifying Clinical Outcomes and Molecular Heterogeneity in Stage II/III Colorectal Cancer (2025 · Advanced Science · 被引 5)
• The Efficacy of Various Weight Loss Strategies in Alleviating Polycystic Ovary Syndrome (2025 · Current Obesity Reports · 被引 5)